SIGNS AGREEMENT WITH A NASDAQ LISTED COMPANY

LifeAssays signs agreement with a NASDAQ listed company

IDEON, Lund - The Swedish Nordic Growth Market (NGM, Stockholm, Sweden) listed stock company LifeAssays AB has signed an agreement with a NASDAQ listed company, which is operating in the diagnostic Point-Of-Care sector. The agreement allows for a 6-month test study involving the detection of a certain blood marker, relevant for monitoring diabetes, using LifeAssays patented platform technology. The NASDAQ listed company commits to pay LifeAssays 62,587 USD for which the company will have a future possibility to acquire ownership and the exclusive world-wide right to exploit the LifeAssays magneto immunoassay technology for the new blood test that could be developed jointly.

The board of LifeAssays